A Novel Inhibitory Receptor (ILT3) Expressed on Monocytes, Macrophages, and Dendritic Cells Involved in Antigen Processing
Open accessThe DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
Immunoglobulin-like transcript (ILT) 3 is a novel cell surface molecule of the immunoglobulin superfamily, which is selectively expressed by myeloid antigen presenting cells (APCs) such as monocytes, macrophages, and dendritic cells. The cytoplasmic region of ILT3 contains putative immunoreceptor tyrosine-based inhibitory motifs that suggest an inhibitory function of ILT3. Indeed, co-ligation of ILT3 to stimulatory receptors expressed by APCs results in a dramatic blunting of the increased [Ca2+]i and tyrosine phosphorylation triggered by these receptors. Signal extinction involves SH2-containing protein tyrosine phosphatase 1, which is recruited by ILT3 upon cross-linking. ILT3 can also function in antigen capture and presentation. It is efficiently internalized upon cross-linking, and delivers its ligand to an intracellular compartment where it is processed and presented to T cells. Thus, ILT3 is a novel inhibitory receptor that can negatively regulate activation of APCs and can be used by APCs for antigen uptake.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Sallusto, F., & Lanzavecchia, A. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.4.1109 · Cited by 5,129 · cited 1×
“Dendritic cells (DCs) were obtained from monocytes as previously described (32).”
MethodSelf-citationThe Dendritic Cell System and its Role in Immunogenicity
Steinman, R. M. (1991) · Annual Review of Immunology · doi:10.1146/annurev.iy.09.040191.001415 · Cited by 4,658
Frohman, M. A., Dush, M. K., & Martin, G. R. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.23.8998 · Cited by 4,577
Sallusto, F., Cella, M., Danieli, C., & Lanzavecchia, A. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.2.389 · Cited by 2,500
Self-citationThe Immunoglobulin Superfamily: Domains For Cell Surface Recognition
Williams, A. (1988) · Annual Review of Immunology · doi:10.1146/annurev.immunol.6.1.381 · Cited by 2,254
Signal transduction by lymphocyte antigen receptors
Weiss, A., & Littman, D. R. (1994) · Cell · doi:10.1016/0092-8674(94)90334-4 · Cited by 2,089
Ravetch, J. V., & Kinet, J. P. (1991) · Annual Review of Immunology · doi:10.1146/annurev.iy.09.040191.002325 · Cited by 1,229
Romani, N., Reider, D., Heuer, M., Ebner, S., Kämpgen, E., Eibl, B., Niederwieser, D., & Schuler, G. (1996) · Journal of Immunological Methods · doi:10.1016/0022-1759(96)00078-6 · Cited by 1,091
CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells.
Zhou, L. J., & Tedder, T. F. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.6.2588 · Cited by 1,067
Cited by
Immunobiology of Dendritic Cells
Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y.-J., Pulendran, B., & Palucka, K. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.767 · Cited by 6,634
Antigen Presentation and T Cell Stimulation by Dendritic Cells
Guermonprez, P., Valladeau, J., Zitvogel, L., Théry, C., & Amigorena, S. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064828 · Cited by 1,926
Cella, M., Jarrossay, D., Facchetti, F., Alebardi, O., Nakajima, H., Lanzavecchia, A., & Colonna, M. (1999) · Nature Medicine · doi:10.1038/11360 · Cited by 1,737
Self-citationLanier, L. L. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.359 · Cited by 1,648
Bouchon, A., Dietrich, J., & Colonna, M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.10.4991 · Cited by 1,284
TREM-1 amplifies inflammation and is a crucial mediator of septic shock
Bouchon, A., Facchetti, F., Weigand, M. A., & Colonna, M. (2001) · Nature · doi:10.1038/35074114 · Cited by 1,090
Self-citationValladeau, J., Ravel, O., Dezutter-Dambuyant, C., Moore, K., Kleijmeer, M., Liu, Y., Duvert-Frances, V., Vincent, C., Schmitt, D., Davoust, J., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)80160-0 · Cited by 962
Colonna, M., Navarro, F., Bellón, T., Llano, M., García, P., Samaridis, J., Angman, L., Cella, M., & López-Botet, M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.11.1809 · Cited by 950
Self-citationREGULATION OF IMMUNE RESPONSES THROUGH INHIBITORY RECEPTORS
Long, E. O. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.875 · Cited by 939
Phagocytosis checkpoints as new targets for cancer immunotherapy
Feng, M., Jiang, W., Kim, B. Y. S., Zhang, C. C., Fu, Y.-X., & Weissman, I. L. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0183-z · Cited by 911
Tolerization of dendritic cells by TS cells: the crucial role of inhibitory receptors ILT3 and ILT4
Chang, C. C., Ciubotariu, R., Manavalan, J. S., Yuan, J., Colovai, A. I., Piazza, F., Lederman, S., Colonna, M., Cortesini, R., Dalla-Favera, R., et al. (2002) · Nature Immunology · doi:10.1038/ni760 · Cited by 800
Self-citationDzionek, A., Sohma, Y., Nagafune, J., Cella, M., Colonna, M., Facchetti, F., Günther, G., Johnston, I., Lanzavecchia, A., Nagasaka, T., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.12.1823 · Cited by 766
Self-citationCharacterization of human blood dendritic cell subsets
MacDonald, K. P. A., Munster, D. J., Clark, G. J., Dzionek, A., Schmitz, J., & Hart, D. N. J. (2002) · Blood · doi:10.1182/blood-2001-11-0097 · Cited by 758
Pessino, A., Sivori, S., Bottino, C., Malaspina, A., Morelli, L., Moretta, L., Biassoni, R., & Moretta, A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.5.953 · Cited by 579
Liang, B., Workman, C., Lee, J., Chew, C., Dale, B. M., Colonna, L., Flores, M., Li, N., Schweighoffer, E., Greenberg, S., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.9.5916 · Cited by 566
“Engagement of ITIM-containing receptor pathways with known MHC ligands functionally inhibit DCs, including Ig-like transcript 3 and ILT4 (7, 8) and paired Ig receptor PIR-B (9–11), but their contribution to CD4 CD25 T: DC interactions are unclear.”
BackgroundObermajer, N., Muthuswamy, R., Lesnock, J., Edwards, R. P., & Kalinski, P. (2011) · Blood · doi:10.1182/blood-2011-07-365825 · Cited by 497
Tolerogenic dendritic cells: cytokine modulation comes of age
Rutella, S., Danese, S., & Leone, G. (2006) · Blood · doi:10.1182/blood-2006-03-006403 · Cited by 491
Colonna, M., Samaridis, J., Cella, M., Angman, L., Allen, R. L., O’Callaghan, C. A., Dunbar, R., Ogg, G. S., Cerundolo, V., & Rolink, A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.7.3096 · Cited by 457
Self-citationPenna, G., Roncari, A., Amuchastegui, S., Daniel, K. C., Berti, E., Colonna, M., & Adorini, L. (2005) · Blood · doi:10.1182/blood-2005-05-2044 · Cited by 412
Self-citationLAIR-1, a Novel Inhibitory Receptor Expressed on Human Mononuclear Leukocytes
Meyaard, L., Adema, G. J., Chang, C., Woollatt, E., Sutherland, G. R., Lanier, L. L., & Phillips, J. H. (1997) · Immunity · doi:10.1016/s1074-7613(00)80530-0 · Cited by 401
Neuroinflammation: Microglia and T Cells Get Ready to Tango
Schetters, S. T. T., Gomez-Nicola, D., Garcia-Vallejo, J. J., & Van Kooyk, Y. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01905 · Cited by 382
Dendritic cell-mediated T cell polarization
de Jong, E. C., Smits, H. H., & Kapsenberg, M. L. (2005) · Springer Seminars in Immunopathology · doi:10.1007/s00281-004-0167-1 · Cited by 367
Most lymphoid organ dendritic cell types are phenotypically and functionally immature
Wilson, N. S., El-Sukkari, D., Belz, G. T., Smith, C. M., Steptoe, R. J., Heath, W. R., Shortman, K., & Villadangos, J. A. (2003) · Blood · doi:10.1182/blood-2003-02-0513 · Cited by 358
Dendritic cell control of tolerogenic responses
Manicassamy, S., & Pulendran, B. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01015.x · Cited by 357
Bleharski, J. R., Kiessler, V., Buonsanti, C., Sieling, P. A., Stenger, S., Colonna, M., & Modlin, R. L. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.7.3812 · Cited by 345
Self-citationNatarajan, K., Dimasi, N., Wang, J., Mariuzza, R. A., & Margulies, D. H. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064812 · Cited by 335
Neisserial binding to CEACAM1 arrests the activation and proliferation of CD4+ T lymphocytes
Boulton, I. C., & Gray-Owen, S. D. (2002) · Nature Immunology · doi:10.1038/ni769 · Cited by 322
High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cells
Manavalan, J. S., Rossi, P. C., Vlad, G., Piazza, F., Yarilina, A., Cortesini, R., Mancini, D., & Suciu-Foca, N. (2003) · Transplant Immunology · doi:10.1016/s0966-3274(03)00058-3 · Cited by 319
Tolerization of dendritic cells by HLA‐G
Ristich, V., Liang, S., Zhang, W., Wu, J., & Horuzsko, A. (2005) · European Journal of Immunology · doi:10.1002/eji.200425741 · Cited by 315
Yokoyama, W. M. (1995) · Current Opinion in Immunology · doi:10.1016/0952-7915(95)80036-0 · Cited by 299
Phenotypic characterization of human decidual macrophages
HEIKKINEN, J., MÖTTÖNEN, M., KOMI, J., ALANEN, A., & LASSILA, O. (2003) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.2003.02092.x · Cited by 293
The LILR family: modulators of innate and adaptive immune pathways in health and disease
Brown, D., Trowsdale, J., & Allen, R. (2004) · Tissue Antigens · doi:10.1111/j.0001-2815.2004.00290.x · Cited by 291
Valladeau, J., Duvert-Frances, V., Pin, J.-J., Dezutter-Dambuyant, C., Vincent, C., Massacrier, C., Vincent, J., Yoneda, K., Banchereau, J., Caux, C., et al. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199909)29:09<2695::aid-immu2695>3.0.co;2-q · Cited by 283
Shiroishi, M., Kuroki, K., Rasubala, L., Tsumoto, K., Kumagai, I., Kurimoto, E., Kato, K., Kohda, D., & Maenaka, K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605228103 · Cited by 280
Bell, D., Young, J. W., & Banchereau, J. (1999) · Advances in Immunology · doi:10.1016/s0065-2776(08)60023-1 · Cited by 277
A Novel Member of the Leukocyte Receptor Complex Regulates Osteoclast Differentiation
Kim, N., Takami, M., Rho, J., Josien, R., & Choi, Y. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011681 · Cited by 273
Bates, E. E. M., Fournier, N., Garcia, E., Valladeau, J., Durand, I., Pin, J.-J., Zurawski, S. M., Patel, S., Abrams, J. S., Lebecque, S., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.4.1973 · Cited by 269
Pende, D., Castriconi, R., Romagnani, P., Spaggiari, G. M., Marcenaro, S., Dondero, A., Lazzeri, E., Lasagni, L., Martini, S., Rivera, P., et al. (2006) · Blood · doi:10.1182/blood-2005-07-2696 · Cited by 268
Allan, D. S. J., Colonna, M., Lanier, L. L., Churakova, T. D., Abrams, J. S., Ellis, S. A., McMichael, A. J., & Braud, V. M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.7.1149 · Cited by 244
“Baf3 cells transfected with CD94/NKG2A (29), CD94/ NKG2C/DAP12 (29), or KIR receptors (30); Jurkat cells transfected with ILT3 (21); RBL cells transfected with ILT4 or ILT5 (20); and P815 cells transfected with ILT1 (22) have been described previously.”
InfluentialSelf-citationImmunogenetics of systemic lupus erythematosus: A comprehensive review
Ghodke-Puranik, Y., & Niewold, T. B. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.08.004 · Cited by 225
Paul, S. P., Taylor, L. S., Stansbury, E. K., & McVicar, D. W. (2000) · Blood · doi:10.1182/blood.v96.2.483.014k40_483_490 · Cited by 202
Aging-Associated Alterations in Mammary Epithelia and Stroma Revealed by Single-Cell RNA Sequencing
Li, C. M.-C., Shapiro, H., Tsiobikas, C., Selfors, L. M., Chen, H., Rosenbluth, J., Moore, K., Gupta, K. P., Gray, G. K., Oren, Y., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108566 · Cited by 184
“…and NK cells also increased—Cd274 (also known as Pd-l1) (Hsu et al., 2018; Lu et al., 2019; Yamazaki et al., 2002) and Lilrb4 (also known as Ilt3) (Cella et al., 1997; Deng et al., 2018; Suciu-Foca and Cortesini, 2007) (Figure 7I)—thereby potentially promoting an immunosuppressive…”
Seiffert, M., Brossart, P., Cant, C., Cella, M., Colonna, M., Brugger, W., Kanz, L., Ullrich, A., & Bühring, H.-J. (2001) · Blood · doi:10.1182/blood.v97.9.2741 · Cited by 183
Self-citationPanelli, M. C., Wunderlich, J., Jeffries, J., Wang, E., Mixon, A., Rosenberg, S. A., & Marincola, F. M. (2000) · Journal of Immunotherapy · doi:10.1097/00002371-200007000-00013 · Cited by 180
“Marco Colonna, Basel, Switzerland) specific for the inhibitory receptors ILT3, 4, and 5 (32).”
BackgroundBrenk, M., Scheler, M., Koch, S., Neumann, J., Takikawa, O., Häcker, G., Bieber, T., & von Bubnoff, D. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803277 · Cited by 176
Allcock, R. J. N., Barrow, A. D., Forbes, S., Beck, S., & Trowsdale, J. (2003) · European Journal of Immunology · doi:10.1002/immu.200310033 · Cited by 173
Impaired dendritic cell maturation and increased TH2 responses in PIR-B−/− mice
Ujike, A., Takeda, K., Nakamura, A., Ebihara, S., Akiyama, K., & Takai, T. (2002) · Nature Immunology · doi:10.1038/ni801 · Cited by 170
“Other close relatives—LIR-2, LIR-5 and LIR-8—are expressed in B cells and/or DC”
BackgroundLILRB receptor-mediated regulation of myeloid cell maturation and function
van der Touw, W., Chen, H.-M., Pan, P.-Y., & Chen, S.-H. (2017) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-017-2023-x · Cited by 167
Hirayasu, K., & Arase, H. (2015) · Journal of Human Genetics · doi:10.1038/jhg.2015.64 · Cited by 129
Fournier, N., Chalus, L., Durand, I., Garcia, E., Pin, J.-J., Churakova, T., Patel, S., Zlot, C., Gorman, D., Zurawski, S., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.3.1197 · Cited by 102
Xie, Y., Wang, X., Wang, W., Pu, N., & Liu, L. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06422-5 · Cited by 80
“ILT3, highly expressed on tumor-associated myeloid cells, promotes their suppressive phenotype [87].”
Evidence for lymphatic Aβ clearance in Alzheimer's transgenic mice
Pappolla, M., Sambamurti, K., Vidal, R., Pacheco-Quinto, J., Poeggeler, B., & Matsubara, E. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.07.012 · Cited by 69
Lewis Marffy, A. L., & McCarthy, A. J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00857 · Cited by 63
Human leukocyte immunoglobulin-like receptors in health and disease
Redondo-García, S., Barritt, C., Papagregoriou, C., Yeboah, M., Frendeus, B., Cragg, M. S., & Roghanian, A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1282874 · Cited by 53
Human inhibitory and activating Ig-like receptors which modulate the function of myeloid cells
Dietrich, J., Nakajima, H., & Colonna, M. (2000) · Microbes and Infection · doi:10.1016/s1286-4579(00)00294-x · Cited by 53
Self-citationLeukocyte immunoglobulin-like receptor subfamily B: therapeutic targets in cancer
Deng, M., Chen, H., Liu, X., Huang, R., He, Y., Yoo, B., Xie, J., John, S., Zhang, N., An, Z., et al. (2021) · Antibody Therapeutics · doi:10.1093/abt/tbab002 · Cited by 53
LILRB3 Supports Immunosuppressive Activity of Myeloid Cells and Tumor Development
Huang, R., Liu, X., Kim, J., Deng, H., Deng, M., Gui, X., Chen, H., Wu, G., Xiong, W., Xie, J., et al. (2024) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-23-0496 · Cited by 24
Metadata
- Authors
- Cella, M., Döhring, C., Samaridis, J., Dessing, M., Brockhaus, M., Lanzavecchia, A., & Colonna, M.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1997-05-19
- Volume
- 185
- Issue
- 10
- Pages
- 1743-1751
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2157569416
- Cited by
- 431
- References
- 62
- FWCI
- 10.84
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.